The subthalamic nucleus (STN) is a major neuromodulation target for the alleviation of
neurological and neuropsychiatric symptoms using deep brain stimulation (DBS). STN-DBS …

Neuromodulation such as deep brain stimulation (DBS) is advancing as a clinical
intervention in several neurological and neuropsychiatric disorders, including Parkinson´ s …

The disruption of pathologically enhanced beta oscillations is considered one of the key
mechanisms mediating the clinical effects of deep brain stimulation on motor symptoms in …

Patients with advanced Parkinson's disease often suffer from severe gait and balance
problems, impacting quality of live and persisting despite optimization of standard therapies …

Objective To investigate the effects of directional subthalamic deep brain stimulation (STN‐
dDBS) on gait and balance disorders, including freezing of gait (FOG), in patients with …

Background Mobile gait sensors represent a compelling tool to objectify the severity of
symptoms in patients with idiopathic Parkinson's disease (iPD), but also to determine the …

Objective: To examine the short-and long-term clinical outcomes of the bilateral subthalamic
nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) on gait and …

Over the last three decades, extensive basic and clinical research has been performed on
the use of subthalamic nucleus (STN) as the preferred deep brain stimulation (DBS) target …

Patients with advanced Parkinson's can be treated by deep brain stimulation (DBS) of the
subthalamic nucleus (STN). This affords a unique opportunity to record from this nucleus …

Background: The relationship between axial symptoms in Parkinson's disease (PD) and
subthalamic deep brain stimulation (STN-DBS) is still unclear. Purpose: We searched for …